Companies Prestige Consumer Healthcare
Prestige Consumer Healthcare (PBH): executive pay, fiscal 2026
Free brief. Every figure links to the company’s own filing.
Velarion Intel: free for 3 days, no card →Email me Prestige Consumer Healthcare’s executive pay brief as a PDF
You get it on this page the moment you ask, and a copy by email. Every figure is cited to its filing.
After the PDF, up to three short notes on the deeper reports for this company. Reply “unsubscribe” to any of them, any time.
CEO vs. named peers47th pct.Of 15 peer CEOs
CEO pay, last three years
- $5,763,133FY2024
- $6,004,547FY2026
CEO total pay was $6,004,547 in fiscal 2026, up from $5,763,133 in fiscal 2024.
FY2026: salary $1,003,564 · bonus $0 · stock awards $4,099,959 · option awards $0
Executives and directors
Jeffrey Zerillo · SVPChristine Sacco · CFORonald Lombardi · CEOWilliam P'Pool · General CounselAdel Mekhail · EVPCeleste A. Clark · Independent DirectorDawn M. Zier · Independent DirectorJames C. D'Arecca · DirectorJohn E. Byom · Lead Independent DirectorJohn F. Kelly · Independent DirectorKatherine A. Hopkins · Independent DirectorMr. Byom · Independent DirectorMr. Kelly · Independent DirectorMs. Hopkins · Independent Director
Frequently asked questions
Who was the highest-paid executive at Prestige Consumer Healthcare in fiscal 2026?
As disclosed, Ronald Lombardi (Chair, President, and Chief Executive Officer) was the highest-paid executive at Prestige Consumer Healthcare in fiscal 2026, with total compensation of $6,004,547.
How does Prestige Consumer Healthcare's chief executive pay compare to its disclosed peer group?
As disclosed, Ronald Lombardi's total compensation ranked at the 47th percentile of Prestige Consumer Healthcare's disclosed peer group.
What is Prestige Consumer Healthcare's CEO-to-median employee pay ratio?
As disclosed, Prestige Consumer Healthcare's CEO-to-median employee pay ratio was 69:1.
How did shareholders vote on Prestige Consumer Healthcare's executive compensation?
As disclosed, 98.81% of shareholders supported Prestige Consumer Healthcare's executive compensation in the latest say-on-pay vote.
How much does Prestige Consumer Healthcare spend in total on board compensation for fiscal 2026?
As disclosed, Prestige Consumer Healthcare reported total board compensation of $2,446,364 for fiscal 2026.
Answers are drawn only from the figures disclosed in this brief and cited to their location in the source filing. Where a figure required for an answer is not disclosed, that is stated rather than estimated.
Full detail
Every table from the filing. Open any section.
Summary compensation table
| Named executive officer | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|
| Ronald Lombardi | $1,003,564 | $0 | $4,099,959 | $0 | $850,000 | $0 | $51,024 | $6,004,547 |
| Chair, President, and Chief Executive Officer | ||||||||
| Christine Sacco | 716,242 | 0 | 1,608,733 | 0 | 364,650 | 0 | 24,203 | 2,713,828 |
| Chief Financial Officer and Chief Operating Officer | ||||||||
| William P'Pool | 565,565 | 0 | 562,024 | 0 | 191,080 | 0 | 13,923 | 1,332,592 |
| Senior Vice President, General Counsel and Corporate Secretary | ||||||||
| Adel Mekhail | 548,549 | 0 | 543,934 | 0 | 221,952 | 0 | 15,908 | 1,330,343 |
| Executive Vice President, Sales and Marketing | ||||||||
| Jeffrey Zerillo | 384,227 | 0 | 381,044 | 0 | 111,404 | 0 | 15,908 | 892,583 |
| Senior Vice President, Operations | ||||||||
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed in the filing, without adjustment.
Three-year trend — total compensation per named executive
| Named executive officer | FY2026 total | FY2025 total | FY2024 total | Δ FY2025→2026 |
|---|---|---|---|---|
| Ronald Lombardi | $6,004,547 | — | $5,763,133 | — |
| Christine Sacco | 2,713,828 | 3,905,601 | 2,000,849 | ↓ −1,191,773 |
| William P'Pool | 1,332,592 | 1,406,460 | 1,343,885 | ↓ −73,868 |
| Adel Mekhail | 1,330,343 | — | 1,318,534 | — |
| Jeffrey Zerillo | 892,583 | — | 862,927 | — |
Prior-year totals as disclosed in the corresponding proxy; deltas are computed values with the derivation shown in the register.
Incentive-plan design — the Compensation Discussion & Analysis
The Compensation and Talent Management Committee intends compensation to approximate the median level of compensation offered to similarly situated executive officers at companies in the Company's peer group.
| CEO STI target (% of salary) | 125% |
|---|---|
| CEO LTI target (% of salary) | — |
| Independent consultant | — |
| Clawback policy | true |
| Anti-hedging | true |
| Anti-pledging | true |
Equity grants and outstanding awards
No plan-based awards are on file for this fiscal year.
Outstanding equity awards at fiscal year-end 2026
| Executive | Award | Shares unvested | Exercise price | Market value unvested |
|---|---|---|---|---|
| Jeffrey Zerillo | RSU | 778 | — | $46,112 |
| Adel Mekhail | RSU | 1,113 | — | 65,968 |
| Adel Mekhail | RSU | 1,167 | — | 69,168 |
| Jeffrey Zerillo | RSU | 1,411 | — | 83,630 |
| Jeffrey Zerillo | RSU | 1,837 | — | 108,879 |
| Adel Mekhail | RSU | 2,014 | — | 119,370 |
| Adel Mekhail | RSU | 2,082 | — | 123,400 |
| Christine Sacco | RSU | 2,225 | — | 131,876 |
| Jeffrey Zerillo | RSU | 2,450 | — | 145,212 |
| Adel Mekhail | RSU | 2,622 | — | 155,406 |
| Adel Mekhail | RSU | 2,709 | — | 160,562 |
| Jeffrey Zerillo | PSU | 2,755 | — | 163,289 |
| Jeffrey Zerillo | PSU | 3,174 | — | 188,123 |
| Adel Mekhail | RSU | 3,505 | — | 207,741 |
| Adel Mekhail | RSU | 3,675 | — | 217,817 |
| Adel Mekhail | PSU | 3,933 | — | 233,109 |
| Christine Sacco | RSU | 4,042 | — | 239,569 |
| Adel Mekhail | PSU | 4,064 | — | 240,873 |
| Adel Mekhail | PSU | 4,530 | — | 268,493 |
| Adel Mekhail | PSU | 4,684 | — | 277,621 |
| Ronald Lombardi | RSU | 4,995 | — | 296,054 |
| Christine Sacco | RSU | 7,008 | — | 415,364 |
| Christine Sacco | RSU | 7,755 | — | 459,639 |
| Christine Sacco | PSU | 9,094 | — | 539,001 |
| Ronald Lombardi | RSU | 9,532 | — | 564,962 |
| Christine Sacco | PSU | 11,632 | — | 689,429 |
| Ronald Lombardi | RSU | 12,352 | — | 732,103 |
| Christine Sacco | RSU | 21,136 | — | 1,252,731 |
| Ronald Lombardi | RSU | 31,468 | — | 1,865,108 |
| Ronald Lombardi | PSU | 37,057 | — | 2,196,368 |
| Ronald Lombardi | PSU | 42,894 | — | 2,542,327 |
Director compensation
| Director | Cash fees | Stock awards | Option awards | Non-equity incentive | All other | Total |
|---|---|---|---|---|---|---|
| John E. ByomIndependent · Lead Independent Director · Audit & Finance · Compensation & Talent Management | $165,502 | $155,040 | — | — | — | $320,542 |
| Mr. ByomIndependent | 165,502 | 155,040 | — | — | — | 320,542 |
| Dawn M. ZierIndependent · Compensation and Talent Management (Chair) · Audit and Finance | 115,000 | 155,040 | — | — | — | 270,040 |
| James C. D'Arecca | 115,000 | 155,040 | — | — | — | 270,040 |
| Celeste A. ClarkIndependent · Nominating and Corporate Governance (Chair) · Compensation & Talent Management | 110,000 | 155,040 | — | — | — | 265,040 |
| Mr. KellyIndependent | 95,000 | 155,040 | — | — | — | 250,040 |
| John F. KellyIndependent · Nominating and Corporate Governance · Compensation and Talent Management | 95,000 | 155,040 | — | — | — | 250,040 |
| Katherine A. HopkinsIndependent · Audit and Finance | 95,000 | 155,040 | — | — | — | 250,040 |
| Ms. HopkinsIndependent | 95,000 | 155,040 | — | — | — | 250,040 |
| Ronald M. LombardiEmployee director · Board Chair | — | — | — | — | — | 0 |
Board fee structure and ownership guideline
| Annual cash retainer | $95,000 |
|---|---|
| Annual equity retainer | $155,000 |
| Per board meeting fee | — |
| Committee chair fees (audit / comp / nom-gov) | 20,000 / 20,000 / 15,000 |
| Stock ownership guideline | $5 |
Total cost of the board
| Component | FY2026 |
|---|---|
| Cash retainers and fees | $1,051,004 |
| Equity awards (grant-date value) | $1,395,360 |
| All other compensation | $0 |
| Total cost of the board | $2,446,364 |
Computed as the sum of the director compensation table rows above; inputs and formula shown in the register.
Peer group, and who names Prestige Consumer Healthcare as a peer
Companies that benchmark against PBH
9 companies name PBH as a compensation peer
The list of companies that name PBH as a peer is temporarily unavailable — recheck shortly.
Disclosed peer group — fiscal year 2026
The compensation peer group as the company disclosed it in its own proxy — the reference set behind the percentile above.
EPC Edgewell Personal Care CompanyCVGW Calavo Growers Inc.ENR Energizer Holdings, Inc.AMPH Amphastar PharmaceuticalsCHD Church & Dwight Co.HELE Helen of Troy LimitedBRBR BellRing Brands, Inc.PCRX Pacira BioSciences, Inc.HAIN Hain Celestial Group, Inc.SPB Spectrum Brands Holdings Inc.SMPL Simply Good Foods CompanyCORT Corcept Therapeutics IncorporatedUTZ Utz BrandsUSNA USANA Health Sciences, Inc.BGS B&G Foods Holdings Corp.
Peer reciprocity
The companies Prestige Consumer Healthcare names as compensation peers that name it back in their own disclosed peer groups.
Edgewell Personal Care Company (EPC)42Energizer Holdings, Inc. (ENR)43Amphastar Pharmaceuticals (AMPH)44Helen of Troy Limited (HELE)45
Chief executive pay against the peer group
Most recent fiscal-year chief executive compensation at each disclosed peer, taken from that company’s own proxy statement.
| Rank | Company | FY | Chief executive | Salary | Stock awards | Option awards | Non-equity incentive | Total |
|---|---|---|---|---|---|---|---|---|
| 1 | Corcept Therapeutics Incorporated | 2025 | Joseph Belanoff | $1,182,333 | $0 | $12,907,718 | $0 | $15,303,551 |
| 2 | Pacira BioSciences, Inc. | 2025 | Frank Lee | 935,308 | 9,215,500 | 0 | 738,810 | 11,636,917 |
| 3 | Energizer Holdings, Inc. | 2025 | Mark LaVigne | 1,045,500 | 8,605,084 | 0 | 1,145,665 | 10,972,516 |
| 4 | Church & Dwight Co. | 2025 | Richard Dierker | 986,580 | 1,770,973 | 5,313,100 | 1,472,656 | 9,799,678 |
| 5 | Edgewell Personal Care Company | 2025 | Rod Little | 1,100,000 | 7,576,100 | — | 907,500 | 9,754,366 |
| 6 | Spectrum Brands Holdings Inc. | 2025 | David Maura | 900,000 | 6,750,004 | 0 | 907,200 | 8,757,036 |
| 7 | Amphastar Pharmaceuticals | 2025 | Jack Yongfeng Zhang | 950,911 | 3,301,981 | 3,302,024 | 361,000 | 8,309,350 |
| 8 | BellRing Brands, Inc. | 2025 | Darcy Horn Davenport | 950,025 | 4,400,000 | 0 | 1,055,715 | 6,563,539 |
| 9 | Prestige Consumer Healthcare | 2026 | Ronald Lombardi | 1,003,564 | 4,099,959 | 0 | 850,000 | 6,004,547 |
| 10 | B&G Foods Holdings Corp. | 2025 | Kenneth Keller | 1,224,258 | 2,625,864 | 0 | 710,437 | 4,589,619 |
| 11 | Hain Celestial Group, Inc. | 2025 | Wendy Davidson | 789,808 | 3,530,682 | 0 | 0 | 4,546,417 |
| 12 | Helen of Troy Limited | 2026 | G. Scott Uzzell | 550,000 | 3,250,000 | 0 | 107,752 | 4,433,124 |
| 13 | Utz Brands | 2025 | Howard Friedman | 968,289 | 2,699,044 | 0 | 609,936 | 4,391,269 |
| 14 | Usana Health Sciences, Inc. | 2025 | Jim Brown | 821,231 | 3,147,020 | 0 | 339,168 | 4,339,625 |
| 15 | Simply Good Foods Company | 2025 | Geoff Tanner | 816,667 | 2,747,758 | — | 748,000 | 4,330,633 |
| 16 | Calavo Growers Inc. | 2024 | Lecil Cole | 66,160 | 0 | 0 | 0 | 77,760 |
Each peer’s compensation is from its most recently filed proxy; fiscal years differ by company. Each peer’s figures come from its own filings; the subject company is highlighted. Peers whose chief executive compensation is outside our coverage universe are stated as such, never left blank.
Incentive design against the same peers
| Company | Annual incentive payout | Long-term vehicle mix | PSU measures include TSR | Compensation consultant |
|---|---|---|---|---|
| Prestige Consumer Healthcare | 68% | PSU 75 · RSU 25 | No | not disclosed |
| Amphastar Pharmaceuticals | not disclosed | Options 50 · RSU 50 | not disclosed | Willis Towers Watson (WTW) |
| B&G Foods Holdings Corp. | not disclosed | not disclosed | not disclosed | Meridian Compensation Partners |
| BellRing Brands, Inc. | 88.9% of target for corporate level NEOs; 92.9% of target for business unit level NEO (Mr. Singh).% | PRSUs 80 · RSUs 20 | Yes — Relative TSR | Aon |
| Calavo Growers Inc. | not disclosed | not disclosed | not disclosed | Pay Governance LLC |
| Church & Dwight Co. | 125% | Options 75 · PSU 15 · RSU 10 | No | Semler Brossy Consulting Group |
| Corcept Therapeutics Incorporated | Dr. Belanoff: 100%; Dr. Guyer: 120%; Mr. Maduck: 80%; Mr. Mokari: 100%; Mr. Robb: 100%% | Stock Options 100 | not disclosed | not disclosed |
| Edgewell Personal Care Company | 66% | not disclosed | No | Meridian |
| Energizer Holdings, Inc. | 87.67% | PSU 70 · RSU 30 | No | Farient |
| Hain Celestial Group, Inc. | not disclosed | RSU 50 · PSU 50 | Yes — Relative TSR versus the S&P Food & Beverage Select Industry Index | ClearBridge Compensation Group, LLC |
| Helen of Troy Limited | 16.3% | PRSU 60 · RSU 40 | No | FW Cook |
| Pacira BioSciences, Inc. | 90% | RSU 80 · PSU 20 | No | Aon |
| Simply Good Foods Company | not disclosed | not disclosed | not disclosed | Mercer |
| Spectrum Brands Holdings Inc. | not disclosed | PSU 70 · RSU 30 | No | WTW |
| Usana Health Sciences, Inc. | 14.6% of base salary for most NEOs; 41.3% for Jim Brown (CEO); 15% for Brent Neidig (whose bonus excluded the Hiya segment)% | not disclosed | Yes — Positive absolute Total Shareholder Return (TSR) | CODA |
| Utz Brands | not disclosed | not disclosed | not disclosed | F.W. Cook |
Read from each company’s Compensation Discussion and Analysis: annual incentive payout as a percentage of target, the disclosed long-term vehicle mix, whether performance-share measures include a total shareholder return component, and the retained compensation consultant. “Not disclosed” appears only where the company’s filing does not state the item.
Say-on-pay history and pay ratio
| Meeting year | Meeting date | For | Against | Abstain | Support | Outcome |
|---|---|---|---|---|---|---|
| 2025 | 2025-08-05 | 46,414,288 | 559,017 | 131,377 | 98.81% | Passed |
| 2024 | 2024-08-06 | 45,329,756 | 878,293 | 16,994 | 98.1% | Passed |
Rows are labeled by annual-meeting year, with the meeting date beside each; the vote held in a given year acts on the prior fiscal year’s compensation.
Say-on-pay — history, company’s computation
| Meeting year | Meeting date | Approval — company’s computation |
|---|---|---|
| 2025 | 2025-08-05 | 98.81%a |
| 2024 | 2024-08-06 | 98.1%b |
a. Voting standard not stated in the filing.
b. Voting standard not stated in the filing.
Approval percentages are the company’s own reported computations under its own stated standard, not recomputed by Velarion. Where a company does not state a standard, none is assumed.
CEO pay ratio
| Ratio (CEO : median employee) | 69 : 1 |
|---|---|
| CEO total compensation | $5,763,133 |
| Median employee compensation | $82,936 |
Insider trades since the proxy
Every insider equity transaction reported on Form 4 after the 2026 proxy statement — acquisitions, dispositions, exercises, and withholdings — and therefore not reflected in any table in that document.
| Insider | Role | Transaction date | Code | Shares | Price | Value | Security | Source |
|---|---|---|---|---|---|---|---|---|
| John F. Kelly | Director | 2026-08-04 | A | 2,981 | $0 | $0 | Common | Form 4 ↗ |
| Dawn M. Zier | Director | 2026-08-04 | A | 2,981 | 0 | 0 | Common | Form 4 ↗ |
| Celeste A. Clark | Director | 2026-08-04 | A | 2,981 | 0 | 0 | Common | Form 4 ↗ |
| James DArecca | Director | 2026-08-04 | A | 2,981 | 0 | 0 | Common | Form 4 ↗ |
| John E. Byom | Director | 2026-08-04 | A | 2,981 | 0 | 0 | Common | Form 4 ↗ |
Transaction codes per Form 4: A acquisition · S open-market sale · F tax withholding · M option exercise · G gift. Value = shares × price as reported. Dividend-equivalent and fractional-share accrual rows (derivative Class A, under $10,000 and under 2,000 shares) are aggregated per date; every row appears in full below.
Sources (45 citations)
Each figure is listed with the filing it comes from, where it appears in that filing, and the value as printed. Any figure can be independently confirmed against the source.
- Section 01, Ronald Lombardi. DEF 14A, filed 2026-06-29. Section “Executive Compensation Tables” · page 58. As printed: 6,004,547. View filing ↗
- Section 01, Christine Sacco. DEF 14A, filed 2026-06-29. Section “Executive Compensation Tables” · page 58. As printed: 2,713,828. View filing ↗
- Section 01, William P'Pool. DEF 14A, filed 2026-06-29. Section “Executive Compensation Tables” · page 58. As printed: 1,332,592. View filing ↗
- Section 01, Adel Mekhail. DEF 14A, filed 2026-06-29. Section “Executive Compensation Tables” · page 58. As printed: 1,330,343. View filing ↗
- Section 01, Jeffrey Zerillo. DEF 14A, filed 2026-06-29. Section “Executive Compensation Tables” · page 58. As printed: 892,583. View filing ↗
- Section 07, pay ratio. DEF 14A, filed 2024-07-05. Section “CEO Pay Ratio”. As printed: 69 : 1. View filing ↗
- Section 08, John E. Byom. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 320,542. View filing ↗
- Section 08, Mr. Byom. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 320,542. View filing ↗
- Section 08, Dawn M. Zier. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 270,040. View filing ↗
- Section 08, James C. D'Arecca. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 270,040. View filing ↗
- Section 08, Celeste A. Clark. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 265,040. View filing ↗
- Section 08, Mr. Kelly. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 250,040. View filing ↗
- Section 08, John F. Kelly. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 250,040. View filing ↗
- Section 08, Katherine A. Hopkins. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 250,040. View filing ↗
- Section 08, Ms. Hopkins. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 250,040. View filing ↗
- Section 08, Ronald M. Lombardi. DEF 14A, filed 2026-06-29. Section “Director Compensation”. As printed: 0. View filing ↗
- Section 02, John F. Kelly 2026-08-04. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Dawn M. Zier 2026-08-04. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, Celeste A. Clark 2026-08-04. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, James DArecca 2026-08-04. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 02, John E. Byom 2026-08-04. Form 4, filed 2026-08-05. Insider equity transaction reported since the proxy statement. View filing ↗
- Section 06, 2025 vote. Form 8-K, filed 2025-08-07. Item 5.07 · say-on-pay result. As reported: 98.81%. View filing ↗
- Section 06, 2024 vote. Form 8-K, filed 2024-08-08. Item 5.07 · say-on-pay result. As reported: 98.1%. View filing ↗
- Section 01 trend, Δ column (computed). Computed. Δ = current-FY total − prior-FY total per named officer.
- Section 09b board cost (computed). Computed. Cash 1,051,004 + equity 1,395,360 + all other 0 = 2,446,364, summed across the director compensation table rows.
- Corcept Therapeutics Incorporated, Section 10b CEO total. DEF 14A, filed 2026-04-17. CEO total compensation as printed in Corcept Therapeutics Incorporated's own proxy. As printed: 15,303,551. View filing ↗
- Pacira BioSciences, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-28. CEO total compensation as printed in Pacira BioSciences, Inc.'s own proxy. As printed: 11,636,917. View filing ↗
- Energizer Holdings, Inc., Section 10b CEO total. DEF 14A, filed 2025-12-12. CEO total compensation as printed in Energizer Holdings, Inc.'s own proxy. As printed: 10,972,516. View filing ↗
- Church & Dwight Co., Section 10b CEO total. DEF 14A, filed 2026-03-19. CEO total compensation as printed in Church & Dwight Co.'s own proxy. As printed: 9,799,678. View filing ↗
- Edgewell Personal Care Company, Section 10b CEO total. DEF 14A, filed 2025-12-22. CEO total compensation as printed in Edgewell Personal Care Company's own proxy. As printed: 9,754,366. View filing ↗
- Spectrum Brands Holdings Inc., Section 10b CEO total. DEF 14A, filed 2026-06-26. CEO total compensation as printed in Spectrum Brands Holdings Inc.'s own proxy. As printed: 8,757,036. View filing ↗
- Amphastar Pharmaceuticals, Section 10b CEO total. DEF 14A, filed 2026-04-13. CEO total compensation as printed in Amphastar Pharmaceuticals's own proxy. As printed: 8,309,350. View filing ↗
- BellRing Brands, Inc., Section 10b CEO total. DEF 14A, filed 2025-12-16. CEO total compensation as printed in BellRing Brands, Inc.'s own proxy. As printed: 6,563,539. View filing ↗
- Prestige Consumer Healthcare (subject), Section 10b CEO total. DEF 14A, filed 2026-06-29. CEO total compensation as printed in Prestige Consumer Healthcare's own proxy. As printed: 6,004,547. View filing ↗
- B&G Foods Holdings Corp., Section 10b CEO total. DEF 14A, filed 2026-04-03. CEO total compensation as printed in B&G Foods Holdings Corp.'s own proxy. As printed: 4,589,619. View filing ↗
- Hain Celestial Group, Inc., Section 10b CEO total. DEF 14A, filed 2025-09-18. CEO total compensation as printed in Hain Celestial Group, Inc.'s own proxy. As printed: 4,546,417. View filing ↗
- Helen of Troy Limited, Section 10b CEO total. DEF 14A, filed 2026-06-24. CEO total compensation as printed in Helen of Troy Limited's own proxy. As printed: 4,433,124. View filing ↗
- Utz Brands, Section 10b CEO total. DEF 14A, filed 2026-03-12. CEO total compensation as printed in Utz Brands's own proxy. As printed: 4,391,269. View filing ↗
- Usana Health Sciences, Inc., Section 10b CEO total. DEF 14A, filed 2026-04-07. CEO total compensation as printed in Usana Health Sciences, Inc.'s own proxy. As printed: 4,339,625. View filing ↗
- Simply Good Foods Company, Section 10b CEO total. DEF 14A, filed 2025-12-17. CEO total compensation as printed in Simply Good Foods Company's own proxy. As printed: 4,330,633. View filing ↗
- Calavo Growers Inc., Section 10b CEO total. DEF 14A, filed 2025-02-28. CEO total compensation as printed in Calavo Growers Inc.'s own proxy. As printed: 77,760. View filing ↗
- Section 10a, Edgewell Personal Care Company reciprocity. DEF 14A. Edgewell Personal Care Company names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Energizer Holdings, Inc. reciprocity. DEF 14A. Energizer Holdings, Inc. names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Amphastar Pharmaceuticals reciprocity. DEF 14A. Amphastar Pharmaceuticals names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗
- Section 10a, Helen of Troy Limited reciprocity. DEF 14A. Helen of Troy Limited names Prestige Consumer Healthcare in its own disclosed peer group (read from its most recent proxy). View filing ↗